Rising demand for personalized medicine is boosting the AI pathology QC market
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Artificial Intelligence (AI) Pathology Quality Control Market Compare Between 2026 And 2030?
The artificial intelligence (AI) pathology quality control market has experienced substantial expansion in recent years. It is projected to increase from $1.78 billion in 2025 to $2.16 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 21.4%. This historical growth can be primarily attributed to factors such as rising pathology workload volumes, the early adoption of digitized pathology slides, the increasing complexity associated with cancer diagnostics, a strong demand for standardized reporting, and the initial implementation of AI-assisted pathology tools.
The artificial intelligence (AI) pathology quality control market is projected to experience rapid expansion in the coming years. Its size is anticipated to reach $4.65 billion by 2030, achieving a compound annual growth rate (CAGR) of 21.1%. This growth during the forecast period is fueled by factors such as increased investments in digital pathology platforms, a surging demand for precision diagnostics, the broadening of AI validation in clinical workflows, the expanding integration of pathology data analytics, and a heightened regulatory focus on diagnostic quality control. Key trends emerging in this period include the wider deployment of AI-based slide quality assessment, the increasing uptake of automated error detection tools, the ongoing standardization of pathology workflows, the extended integration of digital pathology, and a stronger emphasis on ensuring diagnostic accuracy.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Key Drivers Are Affecting The Artificial Intelligence (AI) Pathology Quality Control Market Development?
The growing need for personalized medicine is projected to stimulate the expansion of the artificial intelligence (AI) pathology quality control market in the future. Personalized medicine defines a medical strategy that customizes treatment and prevention plans to an individual’s distinct genetic makeup, lifestyle, and environmental factors. The rising adoption of personalized medicine is largely driven by developments in genomics, which enable precise identification of genetic variations and the creation of tailored treatments for individuals. Artificial intelligence (AI) pathology quality control enhances personalized medicine by providing accurate and consistent diagnostic insights, thus facilitating customized treatment approaches. It aids in reducing diagnostic errors through automated quality assessments, leading to improved accuracy and reliability, and ultimately advancing care specific to each patient. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, stated that the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, representing a notable increase from the 12 approved in 2022. Thus, the escalating demand for personalized medicine will be a key driver for the artificial intelligence (AI) pathology quality control market.
Which Segment Classifications Are Used In The Artificial Intelligence (AI) Pathology Quality Control Market Segment Analysis?
The artificial intelligence (AI) pathology quality control market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Cancer Diagnostics, Infectious Disease Diagnostics, Digital Pathology, Research, Other Applications
4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Software: Image Analysis Software, Diagnostic Decision Support Software, Workflow Management Software, Reporting And Visualization Software
2) By Hardware: Digital Pathology Scanners, Imaging Devices, Servers And Storage Systems, Laboratory Equipment
3) By Services: Implementation Services, Training And Support Services, Maintenance And Upgrade Services, Consulting Services
What Trends Are Transforming The Artificial Intelligence (AI) Pathology Quality Control Market?
Leading firms within the artificial intelligence (AI) pathology quality control market are concentrating on creating sophisticated tools, specifically advanced AI-powered solutions, aimed at improving diagnostic precision, optimizing laboratory processes, and guaranteeing the dependability of pathology information. These advanced AI-powered solutions represent cutting-edge technologies that leverage artificial intelligence to execute intricate operations with increased exactness, rapidity, and effectiveness. For example, in November 2023, PathAI, a US-based biotechnology company, introduced Artifact Detect 1 on its AISight digital pathology platform. This instrument automates the identification and measurement of artifacts in whole slide images (WSI)—these are irrelevant morphological features that have the potential to degrade diagnostic precision. ArtifactDetect reduces incorrect diagnoses and the need for repeat scans by automatically pre-screening slides for any quality problems, thereby boosting accuracy, laboratory operational efficiency, and overall production capacity. Such an advancement facilitates prompt corrective measures, including re-staining or re-scanning, which ultimately refines the digital workflow and preserves valuable resources for both technicians and pathologists.
Which Firms Are Contributing To The Artificial Intelligence (AI) Pathology Quality Control Market Ecosystem?
Major companies operating in the artificial intelligence (AI) pathology quality control market are Roche Diagnostics GmbH, Danaher Corporation, Philips Healthcare, Agilent Technologies Inc., Hologic Inc., Clinisys Group Ltd., Sectra AB, PathAI Inc., OptraSCAN Inc., Paige.AI Inc., Proscia Inc., Quibim S.L., 3DHISTECH Ltd., Visiopharm A/S, Indica Labs Inc., Ibex Medical Analytics Ltd., Aiosyn B.V., DeepBio Inc., Nucleai Ltd., Gestalt Diagnostics LLC
Get The Full Artificial Intelligence (AI) Pathology Quality Control Market Report:
Which Region Leads The Artificial Intelligence (AI) Pathology Quality Control Market In Terms Of Market Share?
North America was the largest region in the artificial intelligence (AI) pathology quality control market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) pathology quality control market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Artificial Intelligence (AI) Pathology Quality Control Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Artificial Intelligence (AI) Pathology Quality Control Market 2026, By The Business Research Company
Artificial Intelligence In Healthcare Diagnosis Market Report 2026
Ai In Medical Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report
Ai In Cancer Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
